Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training

June 25, 2023 updated by: Alexander Klemp, Florida State University

Neither Pre-sleep Nor Post-exercise Protein Consumption Influences Resistance Exercise Training Adaptations in Older Adults

The goal of this clinical trial is to compare the effects of protein consumption before sleep or immediately after exercise during 12 weeks of resistance exercise training in older adults. The main questions it aims to answer are:

Are there differences in muscle growth or strength during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise? Are there differences in cognitive performance during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise?

This study is a randomized double-blind placebo-controlled study. Participants will be randomly allocated into 1 of 3 groups. All three groups will perform the same 12-week resistance exercise training program two times per week and consume 40 g of protein: 1) Immediately post-exercise, 2) 30 minutes prior to sleep, or 3) no supplemental protein (control). Test of muscle growth and strength, and cognitive performance will be measure before, during, and after the exercise training program.

Researchers will compare the 3 conditions to determine if consume protein after exercise or before sleep during 12 weeks of resistance exercise training affects muscle growth and strength, and cognitive performance.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32306
        • Florida State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male between 60-75 years old at the time of enrollment.

Exclusion Criteria:

  • Diagnosis of cardiac or peripheral vascular disease
  • Stroke, kidney dysfunction
  • Metabolic disease
  • Uncontrolled hypertension
  • Orthopedic limitations
  • Skeletal muscle complications
  • Milk allergy
  • Psychiatric conditions
  • Use of psychotropic drugs
  • Cognitive impairment (scoring 26 points or less on the Montreal Cognitive Assessment)
  • Participation in a structured regular exercise program within the past 6 months
  • Actively attempting to increase or decrease body mass
  • Body mass index (BMI) of ≥ 35 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Post-exercise protein
Consumed 40 g of supplemental protein immediately after exercise sessions and in between breakfast and lunch on non-exercise days.

Post-exercise protein group consumed protein immediately after exercise sessions.

Pre-sleep protein group consumed protein 30 minutes before sleep.

Experimental: Pre-sleep protein
Consumed 40 g of supplemental protein 30 minutes before sleep every day.

Post-exercise protein group consumed protein immediately after exercise sessions.

Pre-sleep protein group consumed protein 30 minutes before sleep.

Placebo Comparator: Resistance exercise training only
Did not consume supplemental protein.
Resistance exercise training only group did not consume supplemental protein.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle thickness
Time Frame: Week 0, 6, and 12
Change in muscle thickness of the quadriceps muscles in centimeters from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
Week 0, 6, and 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum muscular strength
Time Frame: Week 0, 6, and 12
Changes in strength of the chest press and leg press exercises in kilograms from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
Week 0, 6, and 12
Muscle power
Time Frame: Week 0, 6, and 12
Changes in power (Watts) during a sit-to-stand task from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
Week 0, 6, and 12
Cognitive performance
Time Frame: Week 0 and 12
Changes in the number of correct responses during the digit symbol substitution task and pattern comparison tests from week 0 (baseline) to week 12 (end of study).
Week 0 and 12
Measures associated appetite
Time Frame: Week 0, 6, and 12
Changes in subjective measures of hunger, satiety, and desire to eat on a 0-100 millimeter (higher values indicating stronger feeling) visual analog scale from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
Week 0, 6, and 12
Total sleep time
Time Frame: Week 0 and 12
Changes in actigraphy watch measured total sleep time in hours from week 0 (baseline) to week 12 (end of study).
Week 0 and 12
Sleep latency
Time Frame: Week 0 and 12
Changes in actigraphy watch measured sleep latency in minutes from week 0 (baseline) to week 12 (end of study).
Week 0 and 12
Measures associated with sleep
Time Frame: Week 0 and 12
Changes in actigraphy watch measured sleep efficiency (ratio of time spent asleep to the time spent in bed) in percentage from week 0 (baseline) to week 12 (end of study).
Week 0 and 12
Nitrogen balance
Time Frame: Week 0 and 12
Changes in urinary nitrogen balance (grams per day) from week 0 (baseline) to week 12 (end of study).
Week 0 and 12
Free insulin-like growth factor 1
Time Frame: Week 0 and 12
Changes in plasma free insulin-like growth factor 1 concentration (nanogram per deciliter) from week 0 (baseline) to week 12 (end of study).
Week 0 and 12
Mood
Time Frame: Week 0 and 12
Changes in the Profile of Mood State rating scale categories of tension, depression, anger, fatigue, confusion, vigor, and total mood disturbance from week 0 (baseline) to week 12 (end of study) via a 1 to 5 scale (higher score indicates stronger feeling).
Week 0 and 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alex O Klemp, PhD, Student

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2017

Primary Completion (Actual)

May 3, 2019

Study Completion (Actual)

May 3, 2019

Study Registration Dates

First Submitted

May 27, 2023

First Submitted That Met QC Criteria

June 25, 2023

First Posted (Actual)

June 28, 2023

Study Record Updates

Last Update Posted (Actual)

June 28, 2023

Last Update Submitted That Met QC Criteria

June 25, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 25996

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Protein

3
Subscribe